Skip to main content
ConvictionStocks
ScreenerEarningsLearn
1D1W1M3M1Y5YMAX
                      

Healthcare

Travere Therapeutics, Inc.

TVTX
$62.51-4.99%

Price is delayed.

Add to watchlist

About Travere Therapeutics, Inc.

Travere Therapeutics develops medicines for rare kidney and metabolic diseases. The company sells Thiola, a medication for cystinuria, a genetic disorder that causes kidney stones, and recently launched Filspari for a kidney disease called IgA Nephropathy. It is also testing experimental treatments for other rare kidney conditions and metabolic disorders.

1D1W1M3M1Y5YMAX
                      
Loading chart...

Chart powered by TradingView Lightweight Charts

ConvictionStocks logo

Plain-English investing education for people who want to understand what they own.

Product

  • Features
  • Pricing
  • Screener
  • Earnings

Resources

  • Learn
  • Glossary

Company

  • Terms of Service
  • Privacy Policy
  • Contact us

ConvictionStocks is for informational purposes only and does not constitute financial advice. We are not a registered investment advisor. Past performance does not guarantee future results.

© 2026 ConvictionStocks. All rights reserved.

Members only

Full research is for ConvictionStocks members

Members read the rest of this page. Where we have it for this company, that is:

  • What each number means, in plain English, with the Wall Street name where the two differ.
  • A plain-English summary of the company.
  • How many analysts cover it, and the count behind each rating.
  • Recent news, dated.
Get full accessSee a sample company page in full

Get the free weekly market digest

The week's biggest movers, every Sunday. No spam.

                                                                                          

Look up another company

No tickers found

Related Research

More Healthcare stocks to explore

MRK

Merck & Co., Inc.

TMO

Thermo Fisher Scientific Inc.

NVO

Novo Nordisk A/S

ABT

Abbott Laboratories

PFE

Pfizer Inc.